Page last updated: 2024-10-31

mianserin and CACH Syndrome

mianserin has been researched along with CACH Syndrome in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holyoak, AL1
Trout, MJ1
White, RP1
Prematuranga, S1
Senthuran, S1

Other Studies

1 other study available for mianserin and CACH Syndrome

ArticleYear
Toxic leukoencephalopathy in the intensive care unit.
    Anaesthesia and intensive care, 2014, Volume: 42, Issue:6

    Topics: Adult; Amphetamines; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Ascorbic Acid; Brain; C

2014